StonvexLoading…
StonvexStonvexStonvexCore line items from UFCS's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $1.39B | $1.25B | $1.10B | $980.29M |
Operating Income | $147.94M | $77.03M | $-39.72M | $12.08M |
Net Income | $118.19M | $61.96M | $-29.70M | $15.03M |
EPS (Diluted) | $4.48 | $2.39 | $-1.18 | $0.59 |
Total Assets | $3.84B | $3.49B | $3.14B | $2.88B |
Total Liabilities | $2.90B | $2.71B | $2.41B | $2.14B |
Cash & Equivalents | $156.33M | $200.95M | $102.05M | $96.65M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 25.52M | 25.38M | 25.27M | 25.21M |